Trial Profile
A Phase II study of ISIS-PKKRx in patients with hereditary angioedema (HAE)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2014
Price :
$35
*
At a glance
- Drugs IONIS PKKRx (Primary)
- Indications Hereditary angioedema
- Focus Therapeutic Use
- Sponsors Ionis Pharmaceuticals
- 16 Sep 2014 New trial record